Thursday, Apr 25 2024 | Time 15:42 Hrs(IST)
image
Business EconomyPosted at: Mar 13 2020 3:33PM


J Mitra & Co Bags the 'Most Emerging Company in Diagnostics Award' at the 10th MT India Healthcare Awards 2020

NEW DELHI, March 13, 2020 /PRNewswire/ -- India's leading in-vitro diagnostics company, J Mitra & Co, has bagged the Most Emerging Company in Diagnostics & Reagents Award at the 10th MT India Healthcare Awards 2020. The Award ceremony was a part of the Medical Fair India that was held in Mumbai. The award was received by Jatin Mahajan, Managing Director of J Mitra & Co.
This year, the theme of the event was Synergy, Idea, Collaboration: Unlocking the Potential of Indian Healthcare. The overarching objective of the awards and conference is to mobilize key stakeholders from both public and private sectors - along with their strengths and innovations - on a common platform that can highlight best-ways forward for everyone who holds a stake in the MedTech space.
Speaking on the occasion, Jatin Mahajan said, "This is an extremely elating moment for us. This date will be etched as a very important one in the corporate history of J Mitra & Company. This award is a great honour. We had never envisaged that the industry would stand by us with this magnanimous gesture of support and goodwill for our endeavours, initiatives and innovations. This recognition and encouragement will further fuel our innovative spirit - help us to better serve mankind."
In December 2019, J Mitra & Co had bagged India's Greatest Brands & Leaders Award for its innovations and innovating spirit. In July, J Mitra & Company was awarded for Innovation & Research in Healthcare at the 7th Global Healthcare Excellence Awards 2019.
J Mitra & Co is a research-based biotechnology company that has been driving innovation in the healthcare (diagnostics) space since 1969. J Mitra and Co has been constantly innovating to bring cost-effective potent solutions for the global healthcare industry.
J Mitra's latest innovation is India's first portable diagnostic solution - the iQuant immunoassay analyzer. Launched in collaboration with IIT Madras' HTIC (Healthcare Technology Innovation Centre), this portable state-of-the-art Fluorescence Immunoassay Analyzer provides quantitative and qualitative determination of blood test parameter - that includes TSH (Thyroid Stimulating Hormone), T3 (Tri-iodo thyronine), T4 (Thyroxin), Vitamin D, Dengue NS1 Antigen, Dengue IgM, Dengue IgG and HbA1c test. With this innovation, various highly-active and sought-after diagnostic solutions are now available across the country and in the remotest of locations at the fraction of a cost.
About J Mitra & Co
Incorporated in 1969, this research-based biotechnology company has completed 50 years towards its mission to serve mankind. The company manufactures a range of tests for infectious diseases like HIV, HBV, HCV, Dengue, Malaria, Typhoid, Leptospira in rapid and ELISA test formats. The other products include a range of anti-Sera products and confirmatory tests like Western Blot for HIV
Apart from a pan-India footprint, we are also the biggest exporter of diagnostics kits from India, and export to more than 45 countries across the entire globe.
For more information, visit- www.jmitra.co.in
Media Contact :
Prasun Peter
[email protected]
+91-9811279008
Communication Consultant
J Mitra & Co

(Disclaimer--Features may vary depending on the regions; subject to change without notice.)
Please log in to get detailed story.
Tags: #J Mitra & Co Bags the 'Most Emerging Company in Diagnostics Award' at the 10th MT India Healthcare Awards 2020
More News
Dr Reddy’s Lab and Nestlé India enter into definitive agreement to form JV company

Dr Reddy’s Lab and Nestlé India enter into definitive agreement to form JV company

25 Apr 2024 | 2:40 PM

Hyderabad, April 25 (UNI) Dr. Reddy’s Laboratories and Nestlé India have entered into a definitive agreement to form a joint venture company to bring innovative nutraceutical brands to consumers in India and other agreed territories.

see more..
SBI General Insurance records 17 pc growth in topline and a profit growth of 30 pc in FY 23-24

SBI General Insurance records 17 pc growth in topline and a profit growth of 30 pc in FY 23-24

25 Apr 2024 | 2:18 PM

Kolkata, Apr 25 (UNI) SBI General Insurance announced its financial results for FY 23-24, recording 17 per cent growth in topline faster than market growth and a profit growth of 30 per cent in FY 23-24.

see more..
Tata Motors accelerates innovation: record 222 patents filed and 333 grants secured in FY24

Tata Motors accelerates innovation: record 222 patents filed and 333 grants secured in FY24

25 Apr 2024 | 1:10 PM

Hyderabad, Apr 25 (UNI) Part of the USD 150 billion Tata group, Tata Motors Limited, India’s leading automobile company, has yet again achieved a significant milestone towards intellectual property rights (IPR) creation with a record-breaking number of 222 Patents and 117 designs applications filed during the year FY24, highest in its history.

see more..

RITES collaborates with DVC for rail infra works

25 Apr 2024 | 1:05 PM

Mumbai, April 25 (UNI) RITES Ltd., a prime transport infrastructure consultancy on Thursday said that it has signed an MoU with Damodar Valley Corporation (DVC), a statutory body under the Ministry of Power, to collaborate for Project Management Consultancy for rail infra works.

see more..

JioCinema to redefine subscription market with launch of Premium Plans

25 Apr 2024 | 12:42 PM

Mumbai, April 25 (UNI) JioCinema, the video streaming platform of Reliance Industries, has rolled out new subscription plans, JioCinema Premium, which will include ad-free content across languages, including original series, movies, children's shows, and TV entertainment on any device, including connected TV sets, for Rs 29 a month.

see more..
image